EMA Raises Industry Fees For EU Pharmacovigilance Services

 
• By Ian Schofield

Companies using the European Medicines Agency’s drug safety services will be paying more from 3 October.

EU - capsule
The EU is charging more for drug safety assessment activities • Source: Shutterstock: Per Bengtsson

More from Europe

More from Geography